Schnitz W M, Lister K A, McCarty G A
Division of Rheumatology and Immunology, Oklahoma Memorial Hospital, Oklahoma City.
Lupus. 1992 May;1(3):187-9. doi: 10.1177/096120339200100311.
Current management of primary or secondary antiphospholipid antibody (aPL) syndromes with known embolic phenomena requiring anticoagulation is empiric in the setting of elective orthopedic procedures. Short-term withdrawal of warfarin with continuance of aspirin and glucocorticoid therapy was undertaken for sequential bilateral knee replacements in a lupus patient with aPL. Her course was successfully managed without thrombo-embolic complications.
